Literature DB >> 20051048

Clinical characteristics of combined pulmonary fibrosis and emphysema.

Yoshiaki Kitaguchi1, Keisaku Fujimoto, Masayuki Hanaoka, Satoshi Kawakami, Takayuki Honda, Keishi Kubo.   

Abstract

UNLABELLED: This study describes the clinical characteristics of patients with CPFE and compares these with patients with COPD. It should therefore be noteworthy that the prevalence of lung cancer might be high in CPFE patients. BACKGROUND AND
OBJECTIVE: Patients with combined pulmonary fibrosis and emphysema (CPFE) are sometimes seen, and we speculate that these patients have some different clinical characteristics from COPD patients. This study clarifies the clinical characteristics of CPFE patients.
METHODS: This was a retrospective study of 47 stable patients with concurrent emphysema and diffuse parenchymal lung disease with fibrosis, based on the findings of chest CT (CPFE patients). The clinical characteristics of CPFE patients were compared with those of emphysema-dominant COPD patients without parenchymal lung disease (COPD patients).
RESULTS: Forty-six of the 47 CPFE patients were male. Paraseptal emphysema was particularly common in the CPFE group. Honeycombing, ground-glass opacities and reticular opacities were present in 75.6%, 62.2% and 84.4% of CPFE patients, respectively. Twenty-two of the 47 CPFE patients (46.8%) had lung cancer. Pulmonary function tests showed that the CPFE group had milder airflow limitation and lower diffusing capacity than the COPD group. Desaturation during 6-min walking test in CPFE patients tended to be more severe than in COPD patients, if the level of FEV1 or 6MWD was equal.
CONCLUSIONS: CPFE patients had some different clinical characteristics in comparison with COPD patients and may also have a high prevalence of lung cancer.

Entities:  

Mesh:

Year:  2009        PMID: 20051048     DOI: 10.1111/j.1440-1843.2009.01676.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  54 in total

1.  Outcomes of lung cancer resection for patients with combined pulmonary fibrosis and emphysema.

Authors:  Mariko Fukui; Kenji Suzuki; Takeshi Matsunaga; Shiaki Oh; Kazuya Takamochi
Journal:  Surg Today       Date:  2015-08-15       Impact factor: 2.549

2.  Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.

Authors:  Seijiro Sato; Terumoto Koike; Takehisa Hashimoto; Hiroyuki Ishikawa; Akira Okada; Takehiro Watanabe; Masanori Tsuchida
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-04-05       Impact factor: 1.520

3.  Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: A case-control study.

Authors:  Kum Ju Chae; Gong Yong Jin; Young Min Han; Yong Seek Kim; Su Bin Chon; Young Sun Lee; Keun Sang Kwon; Hye Mi Choi; David Lynch
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

Review 4.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

5.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

Review 6.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 7.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

8.  The worst of both worlds-combined pulmonary fibrosis and emphysema syndrome.

Authors:  Sheeba Habeeb Ba Aqeel; Abhishek Biswas; Peruvemba S Sriram
Journal:  Ann Transl Med       Date:  2016-05

Review 9.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

10.  Diaphragmatic motion studied by M-mode ultrasonography in combined pulmonary fibrosis and emphysema.

Authors:  Li He; Wanguang Zhang; Jiahong Zhang; Le Cao; Lan Gong; Jingping Ma; He Huang; Jinwu Zeng; Chuanbin Zhu; Jianhua Gong; Yongjian Xu; Zhenxiang Zhang; Jianping Zhao; Huilan Zhang
Journal:  Lung       Date:  2014-05-13       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.